aluates Reports

$ 0.0

Automative

Global Avian Influenza Vaccines Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-11161

Global Avian Influenza Vaccines Market Insights and Forecast to 2028

BUY CHAPTERS

Global Avian Influenza Vaccines Market Research Report 2024

Code: QYRE-Auto-11161

Report

January 2024

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Avian Influenza Vaccines Market Size

The global Avian Influenza Vaccines market was valued at US$ 949 million in 2023 and is anticipated to reach US$ 1386.6 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Avian Influenza Vaccines Market

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.

Report Scope

The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Avian Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Avian Influenza Vaccines Market Report

Report Metric	Details
Report Name	Avian Influenza Vaccines Market
Accounted market size in 2023	US$ 949 million
Forecasted market size in 2030	US$ 1386.6 million
CAGR	5.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	H5+H7 Avian Influenza Vaccines H9 Avian Influenza Vaccines
Segment by Application	Chicken Avian Influenza Vaccines Duck & Goose Avian Influenza Vaccines Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco (Lohmann ), Yebio, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, ChengDu Tecbond, Sindh Poultry Vaccine Centre, Merck Animal Health, Medion, Avimex Animal Health, JOVAC, Bio-Labs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Avian Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Avian Influenza Vaccines Market growing?

Ans: The Avian Influenza Vaccines Market witnessing a CAGR of 5.5% during the forecast period 2024-2030.

What is the Avian Influenza Vaccines Market size in 2030?

Ans: The Avian Influenza Vaccines Market size in 2030 will be US$ 1386.6 million.

What is the market share of major companies in Avian Influenza Vaccines Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Avian Influenza Vaccines Market share by region?

Ans: China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Who are the main players in the Avian Influenza Vaccines Market report?

Ans: The main players in the Avian Influenza Vaccines Market are Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco (Lohmann ), Yebio, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, ChengDu Tecbond, Sindh Poultry Vaccine Centre, Merck Animal Health, Medion, Avimex Animal Health, JOVAC, Bio-Labs

What are the Application segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Applications covered in the Avian Influenza Vaccines Market report are Chicken Avian Influenza Vaccines, Duck & Goose Avian Influenza Vaccines, Other

What are the Type segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Types covered in the Avian Influenza Vaccines Market report are H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines

1 Avian Influenza Vaccines Market Overview

1.1 Product Overview and Scope of Avian Influenza Vaccines

1.2 Avian Influenza Vaccines Segment by Type

1.2.1 Global Avian Influenza Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 H5+H7 Avian Influenza Vaccines

1.2.3 H9 Avian Influenza Vaccines

1.3 Avian Influenza Vaccines Segment by Application

1.3.1 Global Avian Influenza Vaccines Market Value by Application: (2024-2030)

1.3.2 Chicken Avian Influenza Vaccines

1.3.3 Duck & Goose Avian Influenza Vaccines

1.3.4 Other

1.4 Global Avian Influenza Vaccines Market Size Estimates and Forecasts

1.4.1 Global Avian Influenza Vaccines Revenue 2019-2030

1.4.2 Global Avian Influenza Vaccines Sales 2019-2030

1.4.3 Global Avian Influenza Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Avian Influenza Vaccines Market Competition by Manufacturers

2.1 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Avian Influenza Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global Avian Influenza Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Avian Influenza Vaccines, Product Type & Application

2.7 Avian Influenza Vaccines Market Competitive Situation and Trends

2.7.1 Avian Influenza Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Avian Influenza Vaccines Players Market Share by Revenue

2.7.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Avian Influenza Vaccines Retrospective Market Scenario by Region

3.1 Global Avian Influenza Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Avian Influenza Vaccines Global Avian Influenza Vaccines Sales by Region: 2019-2030

3.2.1 Global Avian Influenza Vaccines Sales by Region: 2019-2024

3.2.2 Global Avian Influenza Vaccines Sales by Region: 2025-2030

3.3 Global Avian Influenza Vaccines Global Avian Influenza Vaccines Revenue by Region: 2019-2030

3.3.1 Global Avian Influenza Vaccines Revenue by Region: 2019-2024

3.3.2 Global Avian Influenza Vaccines Revenue by Region: 2025-2030

3.4 North America Avian Influenza Vaccines Market Facts & Figures by Country

3.4.1 North America Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Avian Influenza Vaccines Sales by Country (2019-2030)

3.4.3 North America Avian Influenza Vaccines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Avian Influenza Vaccines Market Facts & Figures by Country

3.5.1 Europe Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Avian Influenza Vaccines Sales by Country (2019-2030)

3.5.3 Europe Avian Influenza Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Avian Influenza Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific Avian Influenza Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Avian Influenza Vaccines Market Facts & Figures by Country

3.7.1 Latin America Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Avian Influenza Vaccines Sales by Country (2019-2030)

3.7.3 Latin America Avian Influenza Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Avian Influenza Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Avian Influenza Vaccines Sales by Type (2019-2030)

4.1.1 Global Avian Influenza Vaccines Sales by Type (2019-2024)

4.1.2 Global Avian Influenza Vaccines Sales by Type (2025-2030)

4.1.3 Global Avian Influenza Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Avian Influenza Vaccines Revenue by Type (2019-2030)

4.2.1 Global Avian Influenza Vaccines Revenue by Type (2019-2024)

4.2.2 Global Avian Influenza Vaccines Revenue by Type (2025-2030)

4.2.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Avian Influenza Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Avian Influenza Vaccines Sales by Application (2019-2030)

5.1.1 Global Avian Influenza Vaccines Sales by Application (2019-2024)

5.1.2 Global Avian Influenza Vaccines Sales by Application (2025-2030)

5.1.3 Global Avian Influenza Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Avian Influenza Vaccines Revenue by Application (2019-2030)

5.2.1 Global Avian Influenza Vaccines Revenue by Application (2019-2024)

5.2.2 Global Avian Influenza Vaccines Revenue by Application (2025-2030)

5.2.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Avian Influenza Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merial

6.1.1 Merial Corporation Information

6.1.2 Merial Description and Business Overview

6.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merial Avian Influenza Vaccines Product Portfolio

6.1.5 Merial Recent Developments/Updates

6.2 QYH Biotech

6.2.1 QYH Biotech Corporation Information

6.2.2 QYH Biotech Description and Business Overview

6.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio

6.2.5 QYH Biotech Recent Developments/Updates

6.3 DHN

6.3.1 DHN Corporation Information

6.3.2 DHN Description and Business Overview

6.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 DHN Avian Influenza Vaccines Product Portfolio

6.3.5 DHN Recent Developments/Updates

6.4 HVRI

6.4.1 HVRI Corporation Information

6.4.2 HVRI Description and Business Overview

6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 HVRI Avian Influenza Vaccines Product Portfolio

6.4.5 HVRI Recent Developments/Updates

6.5 CEVA

6.5.1 CEVA Corporation Information

6.5.2 CEVA Description and Business Overview

6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 CEVA Avian Influenza Vaccines Product Portfolio

6.5.5 CEVA Recent Developments/Updates

6.6 Elanco (Lohmann )

6.6.1 Elanco (Lohmann ) Corporation Information

6.6.2 Elanco (Lohmann ) Description and Business Overview

6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio

6.6.5 Elanco (Lohmann ) Recent Developments/Updates

6.7 Yebio

6.6.1 Yebio Corporation Information

6.6.2 Yebio Description and Business Overview

6.6.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Yebio Avian Influenza Vaccines Product Portfolio

6.7.5 Yebio Recent Developments/Updates

6.8 Zoetis

6.8.1 Zoetis Corporation Information

6.8.2 Zoetis Description and Business Overview

6.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zoetis Avian Influenza Vaccines Product Portfolio

6.8.5 Zoetis Recent Developments/Updates

6.9 FATRO

6.9.1 FATRO Corporation Information

6.9.2 FATRO Description and Business Overview

6.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 FATRO Avian Influenza Vaccines Product Portfolio

6.9.5 FATRO Recent Developments/Updates

6.10 Kyoto Biken

6.10.1 Kyoto Biken Corporation Information

6.10.2 Kyoto Biken Description and Business Overview

6.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio

6.10.5 Kyoto Biken Recent Developments/Updates

6.11 CAVAC

6.11.1 CAVAC Corporation Information

6.11.2 CAVAC Avian Influenza Vaccines Description and Business Overview

6.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.11.4 CAVAC Avian Influenza Vaccines Product Portfolio

6.11.5 CAVAC Recent Developments/Updates

6.12 Ringpu Biology

6.12.1 Ringpu Biology Corporation Information

6.12.2 Ringpu Biology Avian Influenza Vaccines Description and Business Overview

6.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio

6.12.5 Ringpu Biology Recent Developments/Updates

6.13 Vaksindo

6.13.1 Vaksindo Corporation Information

6.13.2 Vaksindo Avian Influenza Vaccines Description and Business Overview

6.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio

6.13.5 Vaksindo Recent Developments/Updates

6.14 ChengDu Tecbond

6.14.1 ChengDu Tecbond Corporation Information

6.14.2 ChengDu Tecbond Avian Influenza Vaccines Description and Business Overview

6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio

6.14.5 ChengDu Tecbond Recent Developments/Updates

6.15 Sindh Poultry Vaccine Centre

6.15.1 Sindh Poultry Vaccine Centre Corporation Information

6.15.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Description and Business Overview

6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio

6.15.5 Sindh Poultry Vaccine Centre Recent Developments/Updates

6.16 Merck Animal Health

6.16.1 Merck Animal Health Corporation Information

6.16.2 Merck Animal Health Avian Influenza Vaccines Description and Business Overview

6.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio

6.16.5 Merck Animal Health Recent Developments/Updates

6.17 Medion

6.17.1 Medion Corporation Information

6.17.2 Medion Avian Influenza Vaccines Description and Business Overview

6.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Medion Avian Influenza Vaccines Product Portfolio

6.17.5 Medion Recent Developments/Updates

6.18 Avimex Animal Health

6.18.1 Avimex Animal Health Corporation Information

6.18.2 Avimex Animal Health Avian Influenza Vaccines Description and Business Overview

6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio

6.18.5 Avimex Animal Health Recent Developments/Updates

6.19 JOVAC

6.19.1 JOVAC Corporation Information

6.19.2 JOVAC Avian Influenza Vaccines Description and Business Overview

6.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.19.4 JOVAC Avian Influenza Vaccines Product Portfolio

6.19.5 JOVAC Recent Developments/Updates

6.20 Bio-Labs

6.20.1 Bio-Labs Corporation Information

6.20.2 Bio-Labs Avian Influenza Vaccines Description and Business Overview

6.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio

6.20.5 Bio-Labs Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Avian Influenza Vaccines Industry Chain Analysis

7.2 Avian Influenza Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Avian Influenza Vaccines Production Mode & Process

7.4 Avian Influenza Vaccines Sales and Marketing

7.4.1 Avian Influenza Vaccines Sales Channels

7.4.2 Avian Influenza Vaccines Distributors

7.5 Avian Influenza Vaccines Customers

8 Avian Influenza Vaccines Market Dynamics

8.1 Avian Influenza Vaccines Industry Trends

8.2 Avian Influenza Vaccines Market Drivers

8.3 Avian Influenza Vaccines Market Challenges

8.4 Avian Influenza Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

Table 1. Global Avian Influenza Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Avian Influenza Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Avian Influenza Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Avian Influenza Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)

Table 5. Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Avian Influenza Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Avian Influenza Vaccines Average Price (USD/K Doses) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Avian Influenza Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Avian Influenza Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Avian Influenza Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Avian Influenza Vaccines Sales by Region (2019-2024) & (M Doses)

Table 18. Global Avian Influenza Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global Avian Influenza Vaccines Sales by Region (2025-2030) & (M Doses)

Table 20. Global Avian Influenza Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global Avian Influenza Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Avian Influenza Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global Avian Influenza Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Avian Influenza Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America Avian Influenza Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)

Table 27. North America Avian Influenza Vaccines Sales by Country (2025-2030) & (M Doses)

Table 28. North America Avian Influenza Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Avian Influenza Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Avian Influenza Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)

Table 32. Europe Avian Influenza Vaccines Sales by Country (2025-2030) & (M Doses)

Table 33. Europe Avian Influenza Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Avian Influenza Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Avian Influenza Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Avian Influenza Vaccines Sales by Region (2019-2024) & (M Doses)

Table 37. Asia Pacific Avian Influenza Vaccines Sales by Region (2025-2030) & (M Doses)

Table 38. Asia Pacific Avian Influenza Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Avian Influenza Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Avian Influenza Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)

Table 42. Latin America Avian Influenza Vaccines Sales by Country (2025-2030) & (M Doses)

Table 43. Latin America Avian Influenza Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Avian Influenza Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Avian Influenza Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Avian Influenza Vaccines Sales by Country (2019-2024) & (M Doses)

Table 47. Middle East & Africa Avian Influenza Vaccines Sales by Country (2025-2030) & (M Doses)

Table 48. Middle East & Africa Avian Influenza Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Avian Influenza Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Avian Influenza Vaccines Sales (M Doses) by Type (2019-2024)

Table 51. Global Avian Influenza Vaccines Sales (M Doses) by Type (2025-2030)

Table 52. Global Avian Influenza Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global Avian Influenza Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global Avian Influenza Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Avian Influenza Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Avian Influenza Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global Avian Influenza Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2019-2024)

Table 59. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2025-2030)

Table 60. Global Avian Influenza Vaccines Sales (M Doses) by Application (2019-2024)

Table 61. Global Avian Influenza Vaccines Sales (M Doses) by Application (2025-2030)

Table 62. Global Avian Influenza Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global Avian Influenza Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global Avian Influenza Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Avian Influenza Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Avian Influenza Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global Avian Influenza Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2019-2024)

Table 69. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2025-2030)

Table 70. Merial Corporation Information

Table 71. Merial Description and Business Overview

Table 72. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 73. Merial Avian Influenza Vaccines Product

Table 74. Merial Recent Developments/Updates

Table 75. QYH Biotech Corporation Information

Table 76. QYH Biotech Description and Business Overview

Table 77. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 78. QYH Biotech Avian Influenza Vaccines Product

Table 79. QYH Biotech Recent Developments/Updates

Table 80. DHN Corporation Information

Table 81. DHN Description and Business Overview

Table 82. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 83. DHN Avian Influenza Vaccines Product

Table 84. DHN Recent Developments/Updates

Table 85. HVRI Corporation Information

Table 86. HVRI Description and Business Overview

Table 87. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 88. HVRI Avian Influenza Vaccines Product

Table 89. HVRI Recent Developments/Updates

Table 90. CEVA Corporation Information

Table 91. CEVA Description and Business Overview

Table 92. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 93. CEVA Avian Influenza Vaccines Product

Table 94. CEVA Recent Developments/Updates

Table 95. Elanco (Lohmann ) Corporation Information

Table 96. Elanco (Lohmann ) Description and Business Overview

Table 97. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 98. Elanco (Lohmann ) Avian Influenza Vaccines Product

Table 99. Elanco (Lohmann ) Recent Developments/Updates

Table 100. Yebio Corporation Information

Table 101. Yebio Description and Business Overview

Table 102. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 103. Yebio Avian Influenza Vaccines Product

Table 104. Yebio Recent Developments/Updates

Table 105. Zoetis Corporation Information

Table 106. Zoetis Description and Business Overview

Table 107. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 108. Zoetis Avian Influenza Vaccines Product

Table 109. Zoetis Recent Developments/Updates

Table 110. FATRO Corporation Information

Table 111. FATRO Description and Business Overview

Table 112. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 113. FATRO Avian Influenza Vaccines Product

Table 114. FATRO Recent Developments/Updates

Table 115. Kyoto Biken Corporation Information

Table 116. Kyoto Biken Description and Business Overview

Table 117. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 118. Kyoto Biken Avian Influenza Vaccines Product

Table 119. Kyoto Biken Recent Developments/Updates

Table 120. CAVAC Corporation Information

Table 121. CAVAC Description and Business Overview

Table 122. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 123. CAVAC Avian Influenza Vaccines Product

Table 124. CAVAC Recent Developments/Updates

Table 125. Ringpu Biology Corporation Information

Table 126. Ringpu Biology Description and Business Overview

Table 127. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 128. Ringpu Biology Avian Influenza Vaccines Product

Table 129. Ringpu Biology Recent Developments/Updates

Table 130. Vaksindo Corporation Information

Table 131. Vaksindo Description and Business Overview

Table 132. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 133. Vaksindo Avian Influenza Vaccines Product

Table 134. Vaksindo Recent Developments/Updates

Table 135. ChengDu Tecbond Corporation Information

Table 136. ChengDu Tecbond Description and Business Overview

Table 137. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 138. ChengDu Tecbond Avian Influenza Vaccines Product

Table 139. ChengDu Tecbond Recent Developments/Updates

Table 140. Sindh Poultry Vaccine Centre Corporation Information

Table 141. Sindh Poultry Vaccine Centre Description and Business Overview

Table 142. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 143. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product

Table 144. Sindh Poultry Vaccine Centre Recent Developments/Updates

Table 145. Merck Animal Health Corporation Information

Table 146. Merck Animal Health Description and Business Overview

Table 147. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 148. Merck Animal Health Avian Influenza Vaccines Product

Table 149. Merck Animal Health Recent Developments/Updates

Table 150. Medion Corporation Information

Table 151. Medion Description and Business Overview

Table 152. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 153. Medion Avian Influenza Vaccines Product

Table 154. Medion Recent Developments/Updates

Table 155. Avimex Animal Health Corporation Information

Table 156. Avimex Animal Health Description and Business Overview

Table 157. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 158. Avimex Animal Health Avian Influenza Vaccines Product

Table 159. Avimex Animal Health Recent Developments/Updates

Table 160. JOVAC Corporation Information

Table 161. JOVAC Description and Business Overview

Table 162. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 163. JOVAC Avian Influenza Vaccines Product

Table 164. JOVAC Recent Developments/Updates

Table 165. Bio-Labs Corporation Information

Table 166. Bio-Labs Description and Business Overview

Table 167. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)

Table 168. Bio-Labs Avian Influenza Vaccines Product

Table 169. Bio-Labs Recent Developments/Updates

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. Avian Influenza Vaccines Distributors List

Table 173. Avian Influenza Vaccines Customers List

Table 174. Avian Influenza Vaccines Market Trends

Table 175. Avian Influenza Vaccines Market Drivers

Table 176. Avian Influenza Vaccines Market Challenges

Table 177. Avian Influenza Vaccines Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Avian Influenza Vaccines

Figure 2. Global Avian Influenza Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Avian Influenza Vaccines Market Share by Type in 2023 & 2030

Figure 4. H5+H7 Avian Influenza Vaccines Product Picture

Figure 5. H9 Avian Influenza Vaccines Product Picture

Figure 6. Global Avian Influenza Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Avian Influenza Vaccines Market Share by Application in 2023 & 2030

Figure 8. Chicken Avian Influenza Vaccines

Figure 9. Duck & Goose Avian Influenza Vaccines

Figure 10. Other

Figure 11. Global Avian Influenza Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Avian Influenza Vaccines Market Size (2019-2030) & (US$ Million)

Figure 13. Global Avian Influenza Vaccines Sales (2019-2030) & (M Doses)

Figure 14. Global Avian Influenza Vaccines Average Price (USD/K Doses) & (2019-2030)

Figure 15. Avian Influenza Vaccines Report Years Considered

Figure 16. Avian Influenza Vaccines Sales Share by Manufacturers in 2023

Figure 17. Global Avian Influenza Vaccines Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Avian Influenza Vaccines Players: Market Share by Revenue in 2023

Figure 19. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Avian Influenza Vaccines Sales Market Share by Country (2019-2030)

Figure 22. North America Avian Influenza Vaccines Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Avian Influenza Vaccines Sales Market Share by Country (2019-2030)

Figure 26. Europe Avian Influenza Vaccines Revenue Market Share by Country (2019-2030)

Figure 27. Germany Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region (2019-2030)

Figure 34. China Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Avian Influenza Vaccines Sales Market Share by Country (2019-2030)

Figure 44. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Avian Influenza Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Avian Influenza Vaccines by Type (2019-2030)

Figure 54. Global Revenue Market Share of Avian Influenza Vaccines by Type (2019-2030)

Figure 55. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2019-2030)

Figure 56. Global Sales Market Share of Avian Influenza Vaccines by Application (2019-2030)

Figure 57. Global Revenue Market Share of Avian Influenza Vaccines by Application (2019-2030)

Figure 58. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2019-2030)

Figure 59. Avian Influenza Vaccines Value Chain

Figure 60. Avian Influenza Vaccines Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Avian Influenza Vaccines Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-11161

Global Avian Influenza Vaccines Market Research Report 2024

FEATURED COMPANIES

Avian Influenza Vaccines Market Size

Avian Influenza Vaccines Market

Report Scope

Scope of Avian Influenza Vaccines Market Report

Chapter Outline

FAQ for this report

How fast is Avian Influenza Vaccines Market growing?

What is the Avian Influenza Vaccines Market size in 2030?

What is the market share of major companies in Avian Influenza Vaccines Market?

What is the Avian Influenza Vaccines Market share by region?

Who are the main players in the Avian Influenza Vaccines Market report?

What are the Application segmentation covered in the Avian Influenza Vaccines Market report?

What are the Type segmentation covered in the Avian Influenza Vaccines Market report?

FEATURED COMPANIES